Disease Characteristics and Burden in Patients With Atopic Dermatitis: Insights From Two Phase 3 Studies of Ruxolitinib Cream

被引：0
|
作者：
Simpson, Eric [1 ]
Lee, Mark [2 ]
Brar, Kanwaljit [3 ]
Kuligowski, Michael [4 ]
Venturanza, May [4 ]
Sun, Kang [4 ]
Toth, Darryl [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Progress Clin Res, San Antonio, TX USA
[3] NYU, Grossman Sch Med, Hassenfeld Childrens Hosp, New York, NY USA
[4] Incyte Corp, Wilmington, DE USA
[5] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
108
引用
收藏
页码：AB35 / AB35
页数：1
相关论文
共 50 条
  • [31] Ruxolitinib cream significantly modulates inflammatory profiles of atopic dermatitis patients
    Owens, S.
    Liu, H.
    Sun, K.
    Venturanza, M.
    Kuligowski, M.
    Howell, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S173 - S173
  • [32] Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
    Blauvelt, Andrew
    Kircik, Leon
    Papp, Kim A.
    Simpson, Eric L.
    Silverberg, Jonathan, I
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Michael E.
    Venturanza, May E.
    Wei, Shaoceng
    Szepietowski, Jacek C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) : 137 - 146
  • [33] Effects of ruxolitinib cream in patients with atopic dermatitis with head and/or neck involvement
    Simpson, E.
    Bissonnette, R.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Silverberg, J. I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S55 - S55
  • [34] Effects of ruxolitinib cream in patients with atopic dermatitis with baseline body surface area ≥10% and Eczema Area and Severity Index score ≥16: Pooled results from two phase 3 studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Eichenfield, Lawrence F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB157 - AB157
  • [35] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: pooled analysis of two phase III, randomized, double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E62 - E63
  • [36] Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream
    Blauvelt, A.
    Szepietowski, J. C.
    Papp, K.
    Simpson, E.
    Silverberg, J. I.
    Kim, B. S.
    Kwatra, S. G.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Kircik, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S55 - S55
  • [37] Effects of ruxolitinib cream on patient-reported quality of life in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Armstrong, April W.
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Kallender, Howard
    Gao, Jessy
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E122 - E123
  • [38] Ruxolitinib Cream Monotherapy Use Demonstrates Maintenance of Disease and Symptom Control With Use As Needed in Adults and Adolescents With Atopic Dermatitis: Pooled Analysis From the Long Term Safety Periods of Two Phase 3 Studies
    Blauvelt, Andrew
    Kircik, Leon
    Simpson, Eric
    Lio, Peter
    Sturm, Daniel
    Kallender, Howard
    Ren, Haobo
    Paranagama, Dilan
    Gao, Jessy
    Eichenfield, Lawrence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB84 - AB84
  • [39] Ruxolitinib Cream Suppresses Th2 Inflammation in Adult Patients With Atopic Dermatitis
    Owens, Sherry
    Howell, Michael D.
    Rumberger, Beth
    Sun, Kang
    Venturanza, May
    Kuligowski, Michael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB128 - AB128
  • [40] RUXOLITINIB CREAM DEMONSTRATES DURABLE LONG-TERM DISEASE CONTROL WITH AS-NEEDED USE IN PATIENTS WITH ATOPIC DERMATITIS
    Geng, B.
    Eichenfield, L.
    Kircik, L.
    Simpson, E.
    Lio, P.
    Sturm, D.
    Ren, H.
    Blauvelt, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S13 - S13
12345